Ilke Aernout

HOGENT University of Applied Sciences and Arts

Also affiliated with Ghent University Hospital, Ghent University, Cancer Research Institute Ghent

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria”.

Alpha-galactosylceramide improves the potency of mRNA LNP vaccines against cancer and intracellular bacteria

Journal of Controlled Release(2024)10.1016/j.jconrel.2024.04.052

N/A

0DataRank · unranked

43 citations

Ilke Aernout, Joke Deprez, Yanou Engelen, Margo De Velder, Lorenzo Franceschini +9 more

Immunopeptidomics Mapping of Listeria monocytogenes T Cell Epitopes in Mice

Molecular & Cellular Proteomics(2024)10.1016/j.mcpro.2024.100829

N/A

0DataRank · unranked

12 citations

Lecia L. Pewe, Patrick Willems, Rupert L. Mayer, Fabien Théry, Caroline Asselman +15 more

The role of mRNA-galsomes and LNPs in enhancing HIV-specific T cell responses across various lymphoid organs

Molecular Therapy — Nucleic Acids(2024)10.1016/j.omtn.2024.102372

N/A

0DataRank · unranked

5 citations

Sabine den Roover, Rein Verbeke, Ilke Aernout, Sofie Meulewater, Joëlle Cosyns +6 more

Preclinical toxicological assessment of an α-galactosylceramide-adjuvanted mRNA cancer vaccine in Wistar Han rats and domestic pigs

Molecular Therapy — Methods & Clinical Development(2025)10.1016/j.omtm.2025.101493

N/A

0DataRank · unranked

1 citations

Margo De Velder, Diethard Reckelbus, Kevin Mwangi, Thomas Ehouarne, Ilke Aernout +20 more